Literature DB >> 20460540

Epigenetic mechanisms of promigratory chemokine CXCL14 regulation in human prostate cancer cells.

Eun Young Song1, Michael R Shurin, Irina L Tourkova, Dmitriy W Gutkin, Galina V Shurin.   

Abstract

Chemokines play the key role in initiating immune responses by regulating the attraction and homing of immune cells to the lymphoid and nonlymphoid tissues. CXCL14 is a chemokine that in tumors may act as chemoattractant for monocytes and dendritic cells (DC), which may modulate antitumor immune responses in certain cancers. In this study, we investigated the mechanisms of loss of CXCL14 in prostate cancer cells. Cell treatment with the demethylating agent 5-aza-2-deoxycytidine resulted in the recovery of CXCL14 mRNA and protein expression. Hypermethylated CpG island sequences encompassing the CXCL14 gene promoter were identified. The restoration of CXCL14 by 5-aza-2-deoxycytidine treatment had functional impact, based on the DC chemoattractant activity of conditioned medium from drug-treated cells. Conversely, CXCL14 removal from conditioned media by affinity chromatography abolished its chemotactic properties, confirming that functionally active CXCL14 was generated in prostate cancer cells by relieving its transcriptional silencing with 5-aza-2-deoxycytidine. Our findings offer the first direct evidence for epigenetic regulation of chemokine expression in tumor cells. Copyright 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20460540      PMCID: PMC4006362          DOI: 10.1158/0008-5472.CAN-10-0427

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  40 in total

1.  Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype.

Authors:  M Toyota; M Ohe-Toyota; N Ahuja; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes.

Authors:  M Giovarelli; P Cappello; G Forni; T Salcedo; P A Moore; D W LeFleur; B Nardelli; E Di Carlo; P L Lollini; S Ruben; S Ullrich; G Garotta; P Musiani
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

3.  Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation.

Authors:  Patrick Schaerli; Katharina Willimann; Lisa M Ebert; Alfred Walz; Bernhard Moser
Journal:  Immunity       Date:  2005-09       Impact factor: 31.745

4.  Modulation of CXCL14 (BRAK) expression in prostate cancer.

Authors:  Steven R Schwarze; Jun Luo; William B Isaacs; David F Jarrard
Journal:  Prostate       Date:  2005-06-15       Impact factor: 4.104

5.  Structural determinants involved in the regulation of CXCL14/BRAK expression by the 26 S proteasome.

Authors:  Francis C Peterson; Jeffery A Thorpe; Adam G Harder; Brian F Volkman; Steven R Schwarze
Journal:  J Mol Biol       Date:  2006-08-26       Impact factor: 5.469

Review 6.  DNA hypermethylation in tumorigenesis: epigenetics joins genetics.

Authors:  S B Baylin; J G Herman
Journal:  Trends Genet       Date:  2000-04       Impact factor: 11.639

7.  Methylation patterns of IGFBP7 in colon cancer cell lines are associated with levels of gene expression.

Authors:  J Lin; M Lai; Q Huang; Y Ma; J Cui; W Ruan
Journal:  J Pathol       Date:  2007-05       Impact factor: 7.996

8.  Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.

Authors:  M Barber; A Murrell; Y Ito; A-T Maia; S Hyland; C Oliveira; V Save; F Carneiro; A L Paterson; N Grehan; S Dwerryhouse; P Lao-Sirieix; C Caldas; R C Fitzgerald
Journal:  J Pathol       Date:  2008-11       Impact factor: 7.996

9.  Epigenetic inactivation of the chromosomal stability control genes BRCA1, BRCA2, and XRCC5 in non-small cell lung cancer.

Authors:  Ming-Ni Lee; Ruo-Chia Tseng; Han-Shui Hsu; Jia-Yang Chen; Ching Tzao; William L Ho; Yi-Ching Wang
Journal:  Clin Cancer Res       Date:  2007-02-01       Impact factor: 12.531

10.  Candidate tumor suppressor gene SLC5A8 is frequently down-regulated by promoter hypermethylation in prostate tumor.

Authors:  Jong Y Park; Weipeng Zheng; Donghwa Kim; Jin Q Cheng; Nagi Kumar; Nazeel Ahmad; Julio Pow-Sang
Journal:  Cancer Detect Prev       Date:  2007-11-26
View more
  24 in total

1.  Association between preeclampsia and the CXC chemokine family (Review).

Authors:  Xijing Liu; L I Dai; Rong Zhou
Journal:  Exp Ther Med       Date:  2015-03-09       Impact factor: 2.447

Review 2.  The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.

Authors:  Sandra M Cardona; Jenny A Garcia; Astrid E Cardona
Journal:  Methods Mol Biol       Date:  2013

3.  PTEN deletion drives aberrations of DNA methylome and transcriptome in different stages of prostate cancer.

Authors:  Chao Wang; Yaping Feng; Chengyue Zhang; David Cheng; Renyi Wu; Yuqing Yang; Davit Sargsyan; Dibyendu Kumar; Ah-Ng Kong
Journal:  FASEB J       Date:  2019-11-29       Impact factor: 5.191

Review 4.  Advances in Research on the Effects and Mechanisms of Chemokines and Their Receptors in Cancer.

Authors:  Jing Xu; Jing-Quan Li; Qi-Lei Chen; Elena A Shestakova; Vsevolod A Misyurin; Vadim S Pokrovsky; Elena M Tchevkina; Hu-Biao Chen; Hang Song; Jian-Ye Zhang
Journal:  Front Pharmacol       Date:  2022-06-13       Impact factor: 5.988

5.  Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasion.

Authors:  Baoping Cao; Yunsheng Yang; Yuanming Pan; Yan Jia; Malcolm V Brock; James G Herman; Mingzhou Guo
Journal:  Discov Med       Date:  2013-10       Impact factor: 2.970

6.  Alterations to DNA methylation and expression of CXCL14 are associated with suboptimal birth outcomes.

Authors:  Clara Y Cheong; Keefe Chng; Mei Kee Lim; Ajith I Amrithraj; Roy Joseph; Rami Sukarieh; Yong Chee Tan; Louiza Chan; Jun Hao Tan; Li Chen; Hong Pan; Joanna D Holbrook; Michael J Meaney; Yap Seng Chong; Peter D Gluckman; Walter Stünkel
Journal:  J Hum Genet       Date:  2014-08-07       Impact factor: 3.172

Review 7.  Regulation of chemokine expression in the tumor microenvironment.

Authors:  Anton V Gorbachev; Robert L Fairchild
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

8.  Antitumor efficacy of C-X-C motif chemokine ligand 14 in hepatocellular carcinoma in vitro and in vivo.

Authors:  Weilin Wang; Pengfei Huang; Lufei Zhang; Jianfeng Wei; Qingsong Xie; Qiang Sun; Xiaohu Zhou; Haiyang Xie; Lin Zhou; Shusen Zheng
Journal:  Cancer Sci       Date:  2013-10-14       Impact factor: 6.716

Review 9.  The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses.

Authors:  Joseph A Westrich; Daniel W Vermeer; Paul L Colbert; William C Spanos; Dohun Pyeon
Journal:  Mol Carcinog       Date:  2020-03-24       Impact factor: 4.784

10.  Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic mice.

Authors:  Ryu-Ichiro Hata; Kazuhito Izukuri; Yasumasa Kato; Soichiro Sasaki; Naofumi Mukaida; Yojiro Maehata; Chihiro Miyamoto; Tetsu Akasaka; Xiaoyan Yang; Yoji Nagashima; Kazuyoshi Takeda; Tohru Kiyono; Masaru Taniguchi
Journal:  Sci Rep       Date:  2015-03-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.